Gregory Bailey, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 13,458 shares at $78.87 ($1.1M) on 2020-10-12, disclosed to the SEC on 2020-10-14.
Open-market sale of $1.1M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.87 | 6,729 | $531K | 50.0% |
| 2 | $78.87 | 6,729 | $531K | 50.0% |
| Total | $78.87 avg | 13,458 | $1.1M | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |